2023-10-11 00:57:53
On October 10, the Yangtze River Delta Synthetic Biology Industry Innovation Park opened in Changzhou National High-tech Zone, creating a source of innovation for the synthetic biology industry and building a “synthetic biology port” in the Yangtze River Delta. Yuan Yingjin, academician of the Chinese Academy of Sciences and professor of Tianjin University, Wang Chengbin, secretary of the Party Committee of Nanjing Normal University, Hua Guihong, president, and Chen Jinhu, secretary of the Municipal Party Committee, attended the opening ceremony.
The Yangtze River Delta Synthetic Biology Industry Innovation Park is located in the Changzhou Life and Health Industrial Park. It is jointly built by the Changzhou Municipal People’s Government, Changzhou High-tech Zone Management Committee and Nanjing Normal University. It uses the Nanjing Normal University Synthetic Biology Industry Research Institute as an industry incubation platform. Build a comprehensive, integrated, open and shared scientific and technological innovation platform, build an innovation chain from industry frontier key technology innovation, achievement incubation and transformation, and green industry demonstration, achieve the gathering of high-level innovative and entrepreneurial talents, and promote the development of the synthetic biology industry. Create a 100 billion industry.
At the ceremony, 20 key projects were signed together, with a total investment of 950 million yuan, including those introduced by the Nanjing Normal University Research Institute with perfect technology, high added value, alternatives to the original manufacturing route (chemical synthesis or natural extraction), and sustainable ” Scientific and technological talent projects such as DHA and EPA functional oils with the “circular” production model, as well as a number of high-tech, high-growth, and High-return, capital-promising industrial projects.
At the same time, the Yangtze River Delta Synthetic Biology Industry Innovation Park established a 2 billion yuan special fund for the synthetic biology industry and a 200 million yuan park development fund, and cooperated with Changzhou Medical Device Association, Nanjing University Biomedicine Industry Alumni Association, Suzhou Biomedicine Industry Alliance and other units Establish connections and build bridges of cooperation.
Municipal leaders Hang Yong and Jiang Pengju attended the opening ceremony.
In recent years, Changzhou’s biopharmaceutical industry has developed strongly. It has a number of innovative technology companies such as Changmao Biochemical, Chuangjian Medical, and Changzhou Institute of Materia Medica, as well as the Changzhou Institute of Synthetic Biology Industry of Southern Normal University and the Engineering Biology Institute of BGI. High-quality synthetic biology industry technology platforms such as the Danghu Research Institute and the “Provincial Recombinant Protein Manufacturing Engineering Laboratory” of NTU Changzhou High-tech Research Institute. As of the end of 2022, there are 202 regulated enterprises in the biopharmaceutical industry in the city, with an output value of 55.82 billion yuan, of which biopharmaceutical product manufacturing has an output value of 3.98 billion yuan. Changzhou National High-tech Zone focuses on the synthetic biology industry and actively seizes opportunities for industrial development. The Changzhou Life and Health Industrial Park has successively signed contracts to settle in WuXi AppTec Hequan Pharmaceuticals, Yangtze River Zilong Pharmaceuticals, United Imaging Medical Technology, Qianhong Biochemicals, and Yipeishang and 28 industrialization projects, with a total investment of more than 30 billion yuan.
The Synthetic Biology Industry Development Seminar was held on the same day.
Scan to open the current page on your phone
1697000138
#Yangtze #River #Delta #Synthetic #Biology #Industry #Innovation #Park #opened #key #projects #signed